CY1106448T1 - Παραγωγα ισοξαζολινης ως αντικαταθλιπτικα - Google Patents
Παραγωγα ισοξαζολινης ως αντικαταθλιπτικαInfo
- Publication number
- CY1106448T1 CY1106448T1 CY20061101693T CY061101693T CY1106448T1 CY 1106448 T1 CY1106448 T1 CY 1106448T1 CY 20061101693 T CY20061101693 T CY 20061101693T CY 061101693 T CY061101693 T CY 061101693T CY 1106448 T1 CY1106448 T1 CY 1106448T1
- Authority
- CY
- Cyprus
- Prior art keywords
- action
- disorders
- activity
- isoxazoline derivatives
- pir
- Prior art date
Links
- 239000000935 antidepressant agent Substances 0.000 title abstract 4
- 229940005513 antidepressants Drugs 0.000 title abstract 4
- 150000002547 isoxazolines Chemical class 0.000 title abstract 3
- 208000019901 Anxiety disease Diseases 0.000 abstract 2
- 230000001430 anti-depressive effect Effects 0.000 abstract 2
- 230000000949 anxiolytic effect Effects 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 230000000694 effects Effects 0.000 abstract 2
- 208000020401 Depressive disease Diseases 0.000 abstract 1
- 239000000670 adrenergic alpha-2 receptor antagonist Substances 0.000 abstract 1
- 239000000164 antipsychotic agent Substances 0.000 abstract 1
- 229940005529 antipsychotics Drugs 0.000 abstract 1
- 230000036506 anxiety Effects 0.000 abstract 1
- 239000002249 anxiolytic agent Substances 0.000 abstract 1
- 229940005530 anxiolytics Drugs 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 125000004429 atom Chemical group 0.000 abstract 1
- 230000037396 body weight Effects 0.000 abstract 1
- 125000004122 cyclic group Chemical group 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 125000005842 heteroatom Chemical group 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 125000001183 hydrocarbyl group Chemical class 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 125000005936 piperidyl group Chemical group 0.000 abstract 1
- 239000000932 sedative agent Substances 0.000 abstract 1
- 230000001624 sedative effect Effects 0.000 abstract 1
- 230000013275 serotonin uptake Effects 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
- 238000004260 weight control Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/20—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Child & Adolescent Psychology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pain & Pain Management (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Abstract
Η εφεύρεση αναφέρεται σε υποκατεστημένα παράγωγα ισοξαζολίνης σύμφωνα με τον Τύπο (I): όπου το Χ = CH?2#191, N-R7, S ή Ο, τα R1, R2 και R3 είναι κάποιοι εξειδικευμένοι υποκαταστάτες, το Pir είναι μία προαιρετικά υποκατέστη μένη ρίζα πιπεριδυλ ή πιπεραζυλ και το R3 αντιπροσωπεύει ένα σύστημα προαιρετικά υποκατεστημένου αρωματικού ομοκυκλικού ή ετεροκυκλικού δακτυλίου που περιλαμβάνει μία αλυσίδα εν μέρει ή εξ ολοκλήρου υδρογονωμένου υδρογονάνθρακα μέγιστου μήκους 6 ατόμων με την οποία το σύστημα δακτυλίου προσαρτάται στη ρίζα Pir και που μπορεί να περιέχει ένα ή περισσότερα ετεροάτομα που επιλέγονται από την ομάδα των Ο, Ν και S˙ μία διαδικασία για την παρασκευή τους, φαρμακευτικές συνθέσεις που τα περιέχουν και τη χρήση τους ως ένα φάρμακο, ιδιαίτερα για τη θεραπευτική αντιμετώπιση της κατάθλιψης και/ή του άγχους και των διαταραχών του σωματικού βάρους. Οι ενώσεις σύμφωνα με την εφεύρεση έχει αποδειχθεί παραδόξως ότι έχουν μία δράση αναστολέα πρόσληψης σεροτονίνης (5-ΗΤ) σε συνδυασμό με επιπλέον δράση ανταγωνιστή α2-αδρενεργικού υποδοχέα και παρουσιάζουν μία ισχυρή αντικαταθλιπτική δράση χωρίς να είναι ηρεμιστικά. Οι ενώσεις σύμφωνα με την εφεύρεση είναι επίσης κατάλληλες για αγωγή σε ασθενείς με διαταραχές άγχους και διαταραχές του σωματικού βάρους. Η εφεύρεση επίσης αναφέρεται σ' ένα νέο συνδυασμό υποκαταστεστημένων παραγώγων ισοξαζολίνης που έχουν αντικαταθλιπτική δράση και/ή αγχολυτική δράση και/ή δράση ελέγχου του σωματικού βάρους με αντικαταθλιπτικά, αγχολυτικά και/ή αντιψυχωσικά για να βελτιωθεί η αποτελεσματικότητα και/ή έναρξη της δράσης.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP01200611 | 2001-02-21 | ||
EP01201264 | 2001-04-05 | ||
EP02712909A EP1368358B1 (en) | 2001-02-21 | 2002-02-13 | Isoxazoline derivatives as anti-depressants |
PCT/EP2002/001567 WO2002066484A1 (en) | 2001-02-21 | 2002-02-13 | Isoxazoline derivatives as anti-depressants |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1106448T1 true CY1106448T1 (el) | 2011-10-12 |
Family
ID=26076836
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20061101693T CY1106448T1 (el) | 2001-02-21 | 2006-11-22 | Παραγωγα ισοξαζολινης ως αντικαταθλιπτικα |
Country Status (33)
Country | Link |
---|---|
US (1) | US7169786B2 (el) |
EP (1) | EP1368358B1 (el) |
JP (1) | JP3953424B2 (el) |
KR (1) | KR100848898B1 (el) |
CN (1) | CN100400540C (el) |
AR (1) | AR035685A1 (el) |
AT (1) | ATE337322T1 (el) |
AU (1) | AU2002244717B2 (el) |
BG (1) | BG107984A (el) |
BR (1) | BR0207433A (el) |
CA (1) | CA2437505C (el) |
CY (1) | CY1106448T1 (el) |
CZ (1) | CZ20032515A3 (el) |
DE (1) | DE60214138T2 (el) |
DK (1) | DK1368358T3 (el) |
EA (1) | EA006747B1 (el) |
EE (1) | EE200300398A (el) |
EG (1) | EG23929A (el) |
ES (1) | ES2271230T3 (el) |
HK (1) | HK1065537A1 (el) |
HR (1) | HRP20030647A2 (el) |
HU (1) | HUP0303270A3 (el) |
IL (2) | IL157470A0 (el) |
MX (1) | MXPA03007432A (el) |
MY (1) | MY137836A (el) |
NO (1) | NO20033700L (el) |
NZ (1) | NZ526741A (el) |
PL (1) | PL208593B1 (el) |
PT (1) | PT1368358E (el) |
SI (1) | SI1368358T1 (el) |
SK (1) | SK11612003A3 (el) |
TW (1) | TWI257392B (el) |
WO (1) | WO2002066484A1 (el) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0203299D0 (en) * | 2002-02-12 | 2002-03-27 | Glaxo Group Ltd | Novel compounds |
DE60316134T2 (de) * | 2002-04-02 | 2008-05-29 | Janssen Pharmaceutica N.V. | Substituierte aminoisoxazolinderivate und ihre verwendung als antidepressiva |
AR040967A1 (es) * | 2002-08-12 | 2005-04-27 | Janssen Pharmaceutica Nv | Derivados de isoxazolina triciclicos c- sustituidos y su uso como anti- depresivos |
CN100522972C (zh) * | 2002-08-15 | 2009-08-05 | 詹森药业有限公司 | 稠合杂环异噁唑啉衍生物和它们作为抗抑郁剂的用途 |
ATE387455T1 (de) * | 2002-08-21 | 2008-03-15 | Janssen Pharmaceutica Nv | C6- und c9-substituierte chromeno(4,3- c)isoxazoline und ihre verwendung als anti- depressiva |
KR20050114641A (ko) | 2003-03-07 | 2005-12-06 | 아스텔라스세이야쿠 가부시키가이샤 | 2,6-이치환된 스티릴을 갖는 질소 함유 헤테로환 유도체 |
EP1905774B1 (en) * | 2003-09-17 | 2013-02-20 | Janssen Pharmaceutica N.V. | Fused heterocyclic compounds as serotonin receptor modulators |
ES2319539T3 (es) * | 2003-09-17 | 2009-05-08 | Janssen Pharmaceutica Nv | Compuestos heterociclicos condensados como moduladores del receptor de serotonina. |
US7635696B2 (en) | 2004-11-26 | 2009-12-22 | Janssen Pharmaceutica N.V. | Isoxazoline-indole derivatives with an improved antipsychotic and anxiolytic activity |
MY147757A (en) * | 2007-03-09 | 2013-01-15 | Sanofi Aventis | Substituted dihydro and tetrahydro oxazolopyrimidinones, preparation and use thereof |
CN101686682A (zh) * | 2007-06-08 | 2010-03-31 | 海利空医疗公司 | 治疗用吡唑并喹啉脲衍生物 |
EP2236511A4 (en) | 2007-12-21 | 2011-04-13 | Alla Chem Llc | LIGANDS OF ALPHA ADRENOCEPTORS AND OF DOPAMINE, HISTAMIN, IMIDAZOLIN AND SEROTONIN RECEPTORS AND THEIR APPLICATION THEREOF |
AR078171A1 (es) | 2009-09-15 | 2011-10-19 | Sanofi Aventis | Dihidrobenzocicloalquiloximetil-oxazolopirimidinonas sustituidas, preparacion y uso de las mismas |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2055011T3 (es) * | 1988-09-19 | 1994-08-16 | Akzo Nv | Un procedimiento para la preparacion de derivados de tetrahidronaftaleno e indano. |
US5880121A (en) * | 1996-01-05 | 1999-03-09 | Hoechst Marion Roussel Inc. | 4,5-dihydronaphth (1,2-c) isoxazoles and derivatives thereof |
NZ329954A (en) * | 1996-04-12 | 1999-07-29 | Janssen Pharmaceutica Nv | Isoxazolidine tetracyclic and tricyclic ring system derivatives and medicaments |
HUP9602763A3 (en) * | 1996-10-09 | 1999-05-28 | Egyt Gyogyszervegyeszeti Gyar | 3-phenyl isoxazole derivatives, process for producing them and pharmaceutical compositions containing the same |
EP1119568B1 (en) * | 1998-10-09 | 2004-02-18 | Janssen Pharmaceutica N.V. | 4,5-dihydro-isoxazole derivatives and their pharmaceutical use |
-
2002
- 2002-02-13 CA CA2437505A patent/CA2437505C/en not_active Expired - Lifetime
- 2002-02-13 CZ CZ20032515A patent/CZ20032515A3/cs unknown
- 2002-02-13 DE DE60214138T patent/DE60214138T2/de not_active Expired - Lifetime
- 2002-02-13 DK DK02712909T patent/DK1368358T3/da active
- 2002-02-13 JP JP2002565998A patent/JP3953424B2/ja not_active Expired - Lifetime
- 2002-02-13 HU HU0303270A patent/HUP0303270A3/hu unknown
- 2002-02-13 SI SI200230433T patent/SI1368358T1/sl unknown
- 2002-02-13 NZ NZ526741A patent/NZ526741A/en unknown
- 2002-02-13 MX MXPA03007432A patent/MXPA03007432A/es active IP Right Grant
- 2002-02-13 US US10/468,555 patent/US7169786B2/en not_active Expired - Lifetime
- 2002-02-13 EE EEP200300398A patent/EE200300398A/xx unknown
- 2002-02-13 PT PT02712909T patent/PT1368358E/pt unknown
- 2002-02-13 IL IL15747002A patent/IL157470A0/xx unknown
- 2002-02-13 AU AU2002244717A patent/AU2002244717B2/en not_active Expired
- 2002-02-13 EP EP02712909A patent/EP1368358B1/en not_active Expired - Lifetime
- 2002-02-13 EA EA200300915A patent/EA006747B1/ru not_active IP Right Cessation
- 2002-02-13 AT AT02712909T patent/ATE337322T1/de not_active IP Right Cessation
- 2002-02-13 SK SK1161-2003A patent/SK11612003A3/sk unknown
- 2002-02-13 WO PCT/EP2002/001567 patent/WO2002066484A1/en active IP Right Grant
- 2002-02-13 CN CNB028052439A patent/CN100400540C/zh not_active Expired - Fee Related
- 2002-02-13 BR BR0207433-8A patent/BR0207433A/pt not_active IP Right Cessation
- 2002-02-13 PL PL363264A patent/PL208593B1/pl unknown
- 2002-02-13 ES ES02712909T patent/ES2271230T3/es not_active Expired - Lifetime
- 2002-02-13 KR KR1020037008328A patent/KR100848898B1/ko not_active IP Right Cessation
- 2002-02-19 EG EG20020197A patent/EG23929A/xx active
- 2002-02-19 MY MYPI20020548A patent/MY137836A/en unknown
- 2002-02-20 AR ARP020100583A patent/AR035685A1/es unknown
- 2002-02-20 TW TW091102853A patent/TWI257392B/zh not_active IP Right Cessation
-
2003
- 2003-07-08 BG BG107984A patent/BG107984A/bg unknown
- 2003-08-12 HR HR20030647A patent/HRP20030647A2/hr not_active Application Discontinuation
- 2003-08-19 IL IL157470A patent/IL157470A/en unknown
- 2003-08-20 NO NO20033700A patent/NO20033700L/no not_active Application Discontinuation
-
2004
- 2004-10-25 HK HK04108329.1A patent/HK1065537A1/xx not_active IP Right Cessation
-
2006
- 2006-11-22 CY CY20061101693T patent/CY1106448T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1106448T1 (el) | Παραγωγα ισοξαζολινης ως αντικαταθλιπτικα | |
EA200600811A1 (ru) | НОВЫЕ ПРОИЗВОДНЫЕ ТЕТРАГИДРОСПИРО {ПИПЕРИДИН-2,7'-ПИРРОЛО [3,2-b]ПИРИДИНА} И НОВЫЕ ПРОИЗВОДНЫЕ ИНДОЛА, ПРИМЕНЕНИЕ ДЛЯ ЛЕЧЕНИЯ РАССТРОЙСТВ, СВЯЗАННЫХ С 5-HT-РЕЦЕПТОРОМ | |
CY1118096T1 (el) | Ρυθμιστες υποδοχεα οπιοειδους | |
BRPI0416212A (pt) | derivado de piridazinona, composição farmacêutica, uso do derivado, método para o tratamento de um sujeito afligido com uma condição ou doença susceptìvel de melhora pela inibição de fosfodiesterase 4 e produto de combinação | |
NO20063599L (no) | Ytterligere heterosykliske forbindelser og deres anvendelse som metabotrofiske glutamatreseptorantagonister | |
SV2002000504A (es) | Derivados biciclicos sustituidos para el tratamiento del crecimiento celular anormal ref.pc10760/20205/bb | |
ATE316076T1 (de) | Benzimidazol-derivate und diese enthaltende pharmazeutische zusammensetzungen | |
NO20053827D0 (no) | Nye forbindelser. | |
CY1106166T1 (el) | Παραγωγα κουιναζολινης ως αναστολεις vegf. | |
ECSP034640A (es) | Derivados de feniletenilo o feniletinilo como antagonistas del receptor del glutamato | |
DE60320012D1 (de) | Aminoheterocyclen als vr-1 antagonisten zur behandlung von schmerzen | |
CY1115117T1 (el) | Παραγωγα υποκατεστημενων οξαζολιδινονων και η χρηση τους ως αναστολεις παραγοντα χα | |
EA200601194A1 (ru) | Новые производные бензофурана, используемые для профилактики или лечения нарушений, связанных с 5-ht-рецептором | |
EA200600048A1 (ru) | Производные бензазепина, используемые для лечения заболеваний, ассоциированных с 5-ht-рецептором | |
DE69011318D1 (de) | Diazinderivate als Angiotensin II Rezeptor Antagonisten. | |
EA200600071A1 (ru) | Производные n-фенилпиперазина и способы профилактики или лечения заболеваний, связанных с 5ht-рецептором | |
DK1747220T3 (da) | Substituerede 1H-pyrrolo[3,2-B, 3,2-C og 2,3-C]pyridin-2-carboxamider og relaterede analoger som inhibitorer af casein kinase I epsilon | |
CL2003002565A1 (es) | Compuestos derivados de 3h-quinazolin-4-ona, su proceso de preparacion, composicion farmaceutica que los contiene, y uso en el tratamiento y prevencion de enfermedades mediadas por inhibidores de mao-b, tales como la enfermedad de alzheimer y demenci | |
BRPI0413013A (pt) | composto, seus sais, solvatos, e derivados farmaceuticamente funcionais, composição farmacêutica, uso de um composto, e, métodos para o tratamento ou profilaxia de condições ou distúrbios, e de doenças | |
Ives et al. | Antidepressant agents | |
DK1673354T3 (da) | Arylindenopyridiner og arylindenopyrimidiner og deres anvendelse som adenosin-A2a-receptorantagonister | |
NO20044645L (no) | Substituerte amino-isoksazolinderivater og deres anvendelse som antidepressive midler | |
NO20065696L (no) | Piperazinderivater av alkyloksindoler som 5-HT7 reseptoraktive midler. | |
HUP0400154A2 (hu) | Heterokondenzált benzoxazepin- és benzoxatiazepin-származékok, alkalmazásuk és az ezeket tartalmazó gyógyászati készítmények | |
MY134287A (en) | C6- and c9-substituted isoxazoline derivatives and their use as anti-depressants |